Effectiveness of Acceptance and Commitment Therapy on death and health anxiety, cognitive and somatic symptoms of anxiety, and component of acceptance and commitment in patients with multiple sclerosis
Not Applicable
- Conditions
- Multiple sclerosis.Multiple sclerosis
- Registration Number
- IRCT2017040833079N2
- Lead Sponsor
- Kashan University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 50
Inclusion Criteria
being female; diagnosis of MS by a neurologist; satisfaction and commitment to participate in the study. Exclusion criteria: get interventions psychological treatment in the past year and the time of study; current mania or psychotic episode history of alcohol abuse or drugs; two sessions of absence for each patient.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Somatic Symptoms of anxiety. Timepoint: Before intervention (baseline), after two month (post). Method of measurement: beck anxiety inventory (BAI).;Death anxiety. Timepoint: Before intervention (baseline), after two month (post). Method of measurement: Death Anxiety Inventory.;Health anxiety. Timepoint: Before intervention (baseline), after two month (post). Method of measurement: Health Anxiety Inventory.;Cognitive Symptoms of anxiety. Timepoint: Before intervention (baseline), after two month (post). Method of measurement: Penn State Worry Questionnaire (PSWQ).;Cognitive fusion. Timepoint: Before intervention (baseline), after two month (post). Method of measurement: cognitive fusion questionaire (CFQ).;Components of acceptance and commitment. Timepoint: Before intervention (baseline), after two month (post). Method of measurement: Acceptance and Action Questionnaire (AAQ-II).
- Secondary Outcome Measures
Name Time Method Therapeutic alliance. Timepoint: after intervention on experimental group. Method of measurement: Working Alliance Inventory-Short Revised (WAI-SR).;MS symptoms. Timepoint: Before intervention (baseline). Method of measurement: Multiple Sclerosis Impact Scale (MSIS-29).